Agents Used in Antiretroviral Therapy
Summary
- Tipranavir boosted with ritonavir is indicated for combination treatment of HIV-infected patients who are treatment experienced and infected with HIV strains resistant to more than 1 PI[FDA Tipranavir]
- Dosing is tipranavir 500 mg with ritonavir 200 mg twice daily
- Tipranavir/ritonavir should not be coadministered with etravirine or other PIs[FDA Tipranavir]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content